Logo
x

Search

Subscribe Now

CSL Behring

PharmaShots Interview: Frank Leebeek & Greta Mulder of Erasmus MC, Lutz Bonacker of CSL Behring Share Insight on Etranacogene Dezaparvovec for the Treatment of Hemophilia B

PharmaShots Interview: Frank Leebeek & Greta Mulder of Erasmus MC, Lutz Bonacker of CSL Behring Share Insight on Etranacogene Deza...

  • April 4, 2022
CSL Behring Presents Results of Etranacogene Dezaparvovec in P-III (HOPE-B) Trial for the Treatment of Hemophilia B at EAHAD 2022

CSL Behring Presents Results of Etranacogene Dezaparvovec in P-III (HOPE-B) Trial for the Treatment of Hemophilia B at EAHAD 2022

  • February 7, 2022
Insights+: COVID-19 Healthcare News Monthly Updates - October 2020

Insights+: COVID-19 Healthcare News Monthly Updates - October 2020

  • October 30, 2020
PharmaShots Weekly Snapshot (Sept 28 - Oct 1, 2020)

PharmaShots Weekly Snapshot (Sept 28 - Oct 1, 2020)

  • October 2, 2020
CSL Behring's Haegarda (C1 Esterase Inhibitor) Receives the US FDA's Approval for Pediatric Patients with Hereditary Angioedema

CSL Behring's Haegarda (C1 Esterase Inhibitor) Receives the US FDA's Approval for Pediatric Patients with Hereditary Angioedema

  • September 29, 2020
Insights+: COVID-19 Healthcare News Monthly Updates - June 2020

Insights+: COVID-19 Healthcare News Monthly Updates - June 2020

  • June 30, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.